Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis

201854 citationsReviewhybrid Open Access

Authors

Rianne A. Weersink

Margriet Bouma · Dutch College of General Practitioners

David M. Burger · Radboud University Medical Center

Joost P.H. Drenth · Radboud University Nijmegen

S. Froukje Harkes‐Idzinga · Royal Dutch Pharmacists Association

Nicole Hunfeld · Erasmus MC

Herold J. Metselaar · Erasmus MC

Abstract

Over 200 recommendations were developed for the safe use of drugs in patients with liver cirrhosis. Implementing these recommendations into clinical practice can possibly enhance medication safety in this vulnerable patient group.

Topics & Keywords

Drug-Induced Hepatotoxicity and Protection Pharmaceutical Practices and Patient Outcomes Pharmacy and Medical Practices

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Drug Safety

Volume 41, Issue 6, pp. 603-613

DOI: 10.1007/s40264-017-0635-x

Field-Weighted Citation Impact: 5.17